StratDeckGSK.L
GSK plc
GSK.L✓Share
Healthcare · Drug Manufacturers - General · United Kingdom
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and...
Price1770.50GBp
1D-0.28%
Market cap100B
AnalystsHold21
Next earnings28 Oct
Loading chart…
Trade ideas
GSK.L isn't in any strategy's Top Picks or Good Opportunities today.
Analysts
ConsensusHold21
Mean score2.61
Mean target2161.48+22.08%
Target range1455.00–3010.00
Value vs sector peers
Fundamentals
P/E15.7
Forward P/E9.7
Price / book4.21
Dividend yield3.84%
Beta0.29
52-week range0.00–2282.0078/100
ADV (USD)129M
Relative volume0.9
10d avg volume4.24M
Revenue growth+5.30%
EPS growth-69.50%
Performance
1D-0.28%
7D-4.12%
1M-5.26%
3M-10.75%
6M-12.81%
YTD-2.93%
In the briefing and the feed
Briefing for 15 SeptNeither the briefing nor the research feed has named GSK.L.
Catalysts
Next earnings: 28 Oct
Trade idea history
No trade idea has fired on GSK.L since the ledger opened.
Get it by email
The board GSK.L sits on, in one five-minute email every weekday before the New York open and on Saturdays: market strength, the biggest movers, earnings coming up and the names sitting at their 200-day EMA.